+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

From
Pregabalin Market 2022-2026 - Product Thumbnail Image

Pregabalin Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
From
From
From
From
From
Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 3092 Pages
  • Global
From
From
From
Neuropathic Pain Drug Market in Canada - Product Thumbnail Image

Neuropathic Pain Drug Market in Canada

  • Report
  • March 2026
  • 338 Pages
  • Canada
From
Neuropathic Pain Drug Market in China - Product Thumbnail Image

Neuropathic Pain Drug Market in China

  • Report
  • March 2026
  • 156 Pages
  • China
From
Neuropathic Pain Drug Market in Germany - Product Thumbnail Image

Neuropathic Pain Drug Market in Germany

  • Report
  • March 2026
  • 174 Pages
  • Germany
From
Neuropathic Pain Drug Market in India - Product Thumbnail Image

Neuropathic Pain Drug Market in India

  • Report
  • March 2026
  • 192 Pages
  • India
From
Tramadol Hydrochloride Tablet Market in Canada - Product Thumbnail Image

Tramadol Hydrochloride Tablet Market in Canada

  • Report
  • February 2026
  • 150 Pages
  • Canada
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more